Ami Fadia

Stock Analyst at Needham

(3.88)
# 713
Out of 4,755 analysts
382
Total ratings
51.32%
Success rate
9.55%
Average return

Stocks Rated by Ami Fadia

Axsome Therapeutics
Feb 10, 2025
Reiterates: Buy
Price Target: $133
Current: $132.20
Upside: +0.61%
Praxis Precision Medicines
Feb 10, 2025
Reiterates: Buy
Price Target: $150
Current: $84.24
Upside: +78.06%
Neurocrine Biosciences
Feb 7, 2025
Reiterates: Hold
Price Target: n/a
Current: $116.85
Upside: -
Immuneering
Feb 6, 2025
Reiterates: Buy
Price Target: $12
Current: $1.80
Upside: +566.67%
Day One Biopharmaceuticals
Jan 13, 2025
Reiterates: Buy
Price Target: $33
Current: $11.92
Upside: +176.85%
Harmony Biosciences Holdings
Jan 13, 2025
Reiterates: Buy
Price Target: $52
Current: $37.74
Upside: +37.78%
Intra-Cellular Therapies
Jan 13, 2025
Downgrades: Hold
Price Target: $100
Current: $127.56
Upside: -21.61%
Bicycle Therapeutics
Jan 13, 2025
Reiterates: Buy
Price Target: $32
Current: $11.64
Upside: +174.91%
Blueprint Medicines
Jan 13, 2025
Reiterates: Buy
Price Target: $135
Current: $101.57
Upside: +32.91%
Avadel Pharmaceuticals
Jan 9, 2025
Maintains: Buy
Price Target: $22$19
Current: $9.00
Upside: +111.11%
Reiterates: Buy
Price Target: $23
Current: $1.67
Upside: +1,277.25%
Reiterates: Buy
Price Target: $207
Current: $129.98
Upside: +59.26%
Downgrades: Hold
Price Target: $15
Current: $8.42
Upside: +78.15%
Reiterates: Buy
Price Target: $85
Current: $40.11
Upside: +111.92%
Maintains: Buy
Price Target: $68$62
Current: $41.45
Upside: +49.58%
Reiterates: Hold
Price Target: n/a
Current: $7.19
Upside: -
Downgrades: Hold
Price Target: $270
Current: $139.39
Upside: +93.70%
Reiterates: Buy
Price Target: $28
Current: $18.49
Upside: +51.43%
Maintains: Outperform
Price Target: $12$16
Current: $0.52
Upside: +2,948.20%
Downgrades: Market Perform
Price Target: $63$75
Current: $27.25
Upside: +175.23%
Maintains: Market Perform
Price Target: $15$23
Current: $1.30
Upside: +1,630.77%
Maintains: Outperform
Price Target: $64$63
Current: $24.20
Upside: +160.33%
Downgrades: Market Perform
Price Target: $12$5
Current: $3.34
Upside: +49.70%
Upgrades: Market Perform
Price Target: n/a
Current: $16.59
Upside: -
Initiates: Outperform
Price Target: $22
Current: $1.66
Upside: +1,225.30%